Inventor · Valencia, CA, US

Keith A. Oberg

29Patents
6h-index
21Co-inventors
65Inventor score

Filing activity: Aug 23, 2004 → Aug 27, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US7799344B2 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents Human Necessities 71 Active
US7803404B2 Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces Human Necessities 68 Active
US8420604B2 Method of drug formulation of compositions comprising crystalline microparticle surfaces Human Necessities 60 Active
US8729019B2 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents Human Necessities 15 Active
US8551055B2 Valves, valved fluid transfer devices and ambulatory infusion devices including the same Human Necessities 10 Active
US8251960B2 Valves, valved fluid transfer devices and ambulatory infusion devices including the same Human Necessities 9 Active
US8740861B2 Valves, valved fluid transfer devices and ambulatory infusion devices including the same Human Necessities 5 Active
US7875008B2 Barrier catheter apparatus and method Human Necessities 5 Active
US8936579B2 Valves, valved fluid transfer devices and ambulatory infusion devices including the same Human Necessities 3 Active
US8936580B2 Valves, valved fluid transfer devices and ambulatory infusion devices including the same Human Necessities 3 Active
US9464969B2 Monoliths Physics 3 Active
US9468717B2 Valves, valved fluid transfer devices and ambulatory infusion devices including the same Human Necessities 2 Active
US9463311B2 Valves, valved fluid transfer devices and ambulatory infusion devices including the same Human Necessities 2 Active
US9089497B2 Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces Human Necessities 0 Active
US10336881B2 Monoliths Physics 0 Active
US9968741B2 Valves, valved fluid transfer devices and ambulatory infusion devices including the same Human Necessities 0 Active
US10143655B2 Method of drug formulation Human Necessities 0 Active
US11013692B2 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents Human Necessities 0 Active
US12214159B2 Insulin infusion set Human Necessities 0 Active
US10357459B2 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents Human Necessities 0 Active
US9446001B2 Increasing drug affinity for crystalline microparticle surfaces Human Necessities 0 Active
US10570439B2 Sample concentration devices Physics 0 Active
US10858690B2 Processing blood samples to detect target nucleic acids Chemistry; Metallurgy 0 Active
US11103459B2 Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces Human Necessities 0 Active
US9283193B2 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.